Skip to content
healthcare.dev
Get a free key

KENGREAL

NDC 10122-620, cangrelor, injection, powder, lyophilized, for solution, from Chiesi USA, Inc..

Product NDC
10122-620
Status
Listed
Labeler
Chiesi USA, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA204958
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10122-620 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CANGRELOR50 mg/1

Pharmacologic classes

Decreased Platelet Aggregation [PE]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]

Package NDCNDC-11Package
10122-620-101012206201010 VIAL, SINGLE-USE in 1 CARTON (10122-620-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (10122-620-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/88b434fa-8891-4fd5-9d86-7ea64667c08f

Use it

Look up 10122-620 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10122-620 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10122-620. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.